Business
LifeStance Reports Fourth Quarter and Full Year 2024 Results
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental
About this update from Lifestance Health Group, Inc.
[{"type":"text","content":"SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted)2024 Highlights and 2025 Outlook Fourth quarter revenue of $325.5 million increased 16% and full year revenue of $1,251.0 million increased 19% compared to revenue of $1,055.7 millionClinician base increased 12% to 7,424 clinicians, a sequential net increase of 155 in the fourth quarter and 779 for the full yearFourth quarter visit volumes increased 14% to 2.0 million and full year visit volumes increased 15% to 7.9 millionNet loss of $7.1 million in the fourth quarter and $57.4 million for the full yearNet cash from operations of $62.3 million in the fourth quarter and $107.3 million for the full yearAdjusted EBITDA of $32.8 million in the fourth quarter and $119.7 million for the full yearFree Cash Flow of $56.0 million in the fourth quarter and $85.7 million for the full yearExpecting full year 2025 revenue of $1.40 billion to $1.44 billion, Center Margin of $440 million to $464 million, and Adjusted EBITDA of $130 million to $150 million “The team delivered exceptional performance in 2024,” said Ken Burdick, Chairman and CEO of LifeStance. “We grew revenue 19%, more than doubled Adjusted EBITDA, and generated strong Free Cash Flow of $86 million. We have delivered consistently strong financial and operational performance over the last two years, and have begun to demonstrate the true potential of LifeStance. Looking ahead to 2025, we feel we are well-positioned to continue our strong momentum while delivering on our mission of expanding access to affordable, high quality mental healthcare.” Financial Highlights Q4 2024 Q4 2023 Y/Y FY 2024 FY 2023 Y/Y (in millions) Total revenue $325.5 $280.6 16% $1,251.0 $1,055.7 19%Income (loss) from operations 1.1 (32.3) (103%) (31.6) (189.1) (83%)Center Margin 109.4 83.3 31% 402.4 302.1 33%Net loss (7.1) (45.0) (84%) (57.4) (186.3) (69%)Adjusted EBITDA 32.8 20.3 62% 119.7 59.0 103%As % of Total revenue: Income (loss) from operations 0.3% (11.5%) (2.5%) (17.9%) Center Margin 33.6% 29.7% 32.2% 28.6% Net loss (2.2%) (16.0%) (4.6%) (17.6%) Adjusted EBITD...